2018-02-01
Interventions for nongenital molluscum contagiosum in persons without immune deficiency
Publication
Publication
JAMA Dermatology , Volume 154 - Issue 2 p. 203- 204
CLINICAL QUESTION
How effective and safe are treatments for nongenital molluscum contagiosum in persons without immune deficiency?
BOTTOM LINE
Compared with placebo, imiquimod, 5%, cream was not more effective in clearing molluscum contagiosum and caused more local adverse effects, including application site reactions, in children aged 2 to 12 years; because high-quality evidence for other interventions is lacking, allowing for natural resolution of the infection remains a reasonable approach.
Additional Metadata | |
---|---|
doi.org/10.1001/jamadermatol.2017.5118, hdl.handle.net/1765/104758 | |
JAMA Dermatology | |
Organisation | Department of General Practice |
van der Wouden, H., Koning, S., & Katz, K.A. (Kenneth A.). (2018). Interventions for nongenital molluscum contagiosum in persons without immune deficiency. JAMA Dermatology (Vol. 154, pp. 203–204). doi:10.1001/jamadermatol.2017.5118 |